Advertiment
Haeno H, Michor F.
Computational Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Cancer is a leading cause of morbidity and mortality in many countries. Solid tumors generally initiate at one particular site called the primary tumor, but eventually disseminate and form new colonies in other organs. The development of such metastases greatly diminishes the potential for a cure of patients and is thought to represent the final stage of the multi-stage progression of human cancer. The concept of early metastatic dissemination, however, postulates that cancer cell spread might arise early during the development of a tumor. It is important to know whether metastases are present at diagnosis since this determines treatment strategies and outcome. In this paper, we design a stochastic mathematical model of the evolution of tumor metastases in an expanding cancer cell population. We calculate the probability of metastasis at a given time during tumor evolution, the expected number of metastatic sites, and the total number of cancer cells as well as metastasized cells. Furthermore, we investigate the effect of drug administration and tumor resection on these quantities and predict the survival time of cancer patients. The model presented in this paper allows us to determine the probability and number of metastases at diagnosis and to identify the optimum treatment strategy to maximally prolong survival of cancer patients. 2009 Elsevier Ltd. All rights reserved.
J Theor Biol. 2010 Mar 7;263(1):30-44. Epub 2009 Nov 14.
Leave a Reply
Suggested Posts
Two Cancer-Promoting Pathways Linked In Esophageal Cancer Hae o H, Michor F. Computatio al Biology Program, Memorial Sloa -Ketteri g Ca cer Ce ter, New York, NY 10065, USA. Ca cer is a leadi g cause of morbidity a d mortality i ma y cou tries. Solid tumors ge erally i itiate at o e particular site called the primary tumor, but eve tually dissemi ate a d form ew colo ies i other orga s. The developme t of such metastases [...]. Posted March 22nd, 2010 | 3:53 am
GSK announces positive vote from FDA panel for pazopanib in certain advanced soft tissue sarcomas Hae o H, Michor F. Computatio al Biology Program, Memorial Sloa -Ketteri g Ca cer Ce ter, New York, NY 10065, USA. Ca cer is a leadi g cause of morbidity a d mortality i ma y cou tries. Solid tumors ge erally i itiate at o e particular site called the primary tumor, but eve tually dissemi ate a d form ew colo ies i other orga s. The developme t of such metastases [...]. Posted March 22nd, 2010 | 3:53 am
FDA To Review Potential New Use Of XGEVA® (Denosumab) At Oncologic Drugs Advisory Committee Meeting Hae o H, Michor F. Computatio al Biology Program, Memorial Sloa -Ketteri g Ca cer Ce ter, New York, NY 10065, USA. Ca cer is a leadi g cause of morbidity a d mortality i ma y cou tries. Solid tumors ge erally i itiate at o e particular site called the primary tumor, but eve tually dissemi ate a d form ew colo ies i other orga s. The developme t of such metastases [...]. Posted March 22nd, 2010 | 3:53 am
FDA Approves Incyte’s Jakafi(TM) (Ruxolitinib) for Patients With Myelofibrosis Hae o H, Michor F. Computatio al Biology Program, Memorial Sloa -Ketteri g Ca cer Ce ter, New York, NY 10065, USA. Ca cer is a leadi g cause of morbidity a d mortality i ma y cou tries. Solid tumors ge erally i itiate at o e particular site called the primary tumor, but eve tually dissemi ate a d form ew colo ies i other orga s. The developme t of such metastases [...]. Posted March 22nd, 2010 | 3:53 am
Glucose Necessary For Cancer Growth May Prove To Be Its Weak Link Hae o H, Michor F. Computatio al Biology Program, Memorial Sloa -Ketteri g Ca cer Ce ter, New York, NY 10065, USA. Ca cer is a leadi g cause of morbidity a d mortality i ma y cou tries. Solid tumors ge erally i itiate at o e particular site called the primary tumor, but eve tually dissemi ate a d form ew colo ies i other orga s. The developme t of such metastases [...]. Posted March 22nd, 2010 | 3:53 am